Skip to main content
Log in

Truncated GLP-1 (proglucagon 78–107-amide) inhibits gastric and pancreatic functions in man

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We studied the effect of intravenous infusion of synthetic truncated GLP-1 (proglucagon 78–107-amide) on fasting and postprandial gastric acid secretion, gastric emptying, and pancreatic secretion of trypsin and lipase in eight normal volunteers using marker dilution and aspiration technique. The infusion resulted in a plasma concentration of 110±14 pmol/liter (mean±SEM). Truncated GLP-1 significantly inhibited postprandial acid secretion by 43±11%, in spite of unchanged plasma gastrin concentration. Gastric emptying rate decreased significantly; 50% emptying time increased from 16±2 min to 30±5 min. Postprandial trypsin and lipase outputs were significantly inhibited by 47±17% and 40±9%, during truncated GLP-1 infusion. Pancreatic enzyme output was linearly correlated to gastric emptying, and truncated GLP-1 did not affect this relationship, suggesting that the effect on pancreatic secretion was secondary to the effect on gastric emptying. Postprandial insulin and glucagon concentrations were similar with and without truncated GLP-1 infusion in spite of significantly lower blood glucose levels (5.2 ±0.2 versus 3.7±0.3), indicating that GLP-1 stimulated insulin secretion and inhibited glucagon secretion. In conclusion, our results suggest that truncated GLP-1 act as a physiological inhibitor of gastric and pancreatic functions in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF: Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranslational processing. J Biol Chem 261:11880–11886, 1986

    Google Scholar 

  2. Novak U, Wilks A, Buell G, McEven S: Identical mRNA for preproglucagon in pancreas and the gut. Eur J Biochem 164:553–557, 1987

    Google Scholar 

  3. Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from the pig small intestine, but not pancreas. Endocrinology 119:1467–1475, 1986

    Google Scholar 

  4. Holst JJ: Enteroglucagon. Adv Metab Dis 11:392–419, 1988

    Google Scholar 

  5. Ørskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874–881, 1987

    Google Scholar 

  6. Holst JJ, Ørskov C, Nielsen OV, Schwartz TW: Truncated glucagon-like 1, an insulin-releasing hormone from distal gut. FEBS Lett 211:169–174, 1987

    Google Scholar 

  7. Ørskov C, Bersani M, Johnsen AH, Højrup P, Holst JJ: Complete sequence of glucagon-like peptide (GLP-1) from human and pig small intestine. J Biol Chem 264:12826–12829 1989

    Google Scholar 

  8. Kreyman B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide 1 7–36: A physiological incretin in man. Lancet 2:1300–1304, 1987

    Google Scholar 

  9. Mojsov S, Weir GO, Habener JF: Insulinotropin: Glucagon-like peptide 1 (7–37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616–619, 1987

    Google Scholar 

  10. Ørskov C, Holst JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1 (proglucagon 78–107-amide) on endocrine secretion from pig pancreas, antrum, and stomach. Endocrinology 123:2009–2013, 1988

    Google Scholar 

  11. Christiansen J, Holst JJ, Kalaja E: Inhibition of gastric acid in man by exogenous and endogenous pancreatic glucagon. Gastroenterology 70:688–692, 1976

    Google Scholar 

  12. Schjoldager BTG, Baldissera FGA, Mortensen PE, Holst JJ, Christiansen J: Oxyntomodulin: A potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499–503, 1988

    Google Scholar 

  13. Schjoldager BTG, Mortensen PE, Myhren J, Christiansen J, Holst JJ: Oxyntomodulin from distal gut: Role in regulation of gastric and pancreatic function. Dig Dis Sci 34:1411–1419, 1989

    Google Scholar 

  14. Schjoldager BTG, Mortensen PE, Christiansen J, Ørskov C, Holst JJ: GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of the human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 34:703–708, 1989

    Google Scholar 

  15. O'Halloran DJ, Nikou GC, Kreyman B, Ghatei MA, Bloom SR: Glucagon-like peptide-1 (7–36)-NH2: A physiological inhibitor of the gastric acid secretion in man. J Endocrinol 126:169–173, 1990

    Google Scholar 

  16. Ørskov C, Holst JJ: Radioimmunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 47:165–174, 1987

    Google Scholar 

  17. Schjoldager BTG, Lawaetz O, Christiansen J: Effect of pancreatic glucagon and its 1–21 fragment on gastric emptying in man. Scand J Gastroenterol 23:726–730, 1988

    Google Scholar 

  18. Lawaetz O, Ohlsen HP, Andreasen R: Evaluation of gastric emptying by a single isotope technique. Scand J Gastroenterol 16:737–748, 1981

    Google Scholar 

  19. Go VLW, Hofmann AF, Summerskill WHJ: Simultaneous measurements of total pancreatic, biliary and gastric outputs in man using a perfusion technic. Gastroenterology 58:321–328, 1970

    Google Scholar 

  20. Dimagno EP: Alternations and consequences of interdigestive and poststimulatory human exocrine pancreatic secretion in health and disease. Scand J Gastroenterol 12(suppl 87): 69, 1983

    Google Scholar 

  21. Worning H, Müllertz S: pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroenterol 1:268–283, 1966

    Google Scholar 

  22. Ørskov C, Jeppesen J, Madsbad S, Holst JJ: Proglucagon products in plasma of non-insulindependent diabetics and nondiabetic controls in the fasting state and following oral glucose and intravenous arginine. J Clin Invest 87:415–423, 1991

    Google Scholar 

  23. Holst JJ, Creutzfeldt M, Holm G, Jensen E, Poulsen D, Sparsø B, Schmidt A: Persistent glucagonemia after pancreatectomy in pigs. Diabete Metab 4:75–79, 1978

    Google Scholar 

  24. Stadil F, Refeldt JF: Determination of gastrin in serum. Scand J Gastrenterol 8:101, 1973

    Google Scholar 

  25. Albanc JDM, Ekins RP, Maritz G, Turner RC: A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free serum hormone moieties. Acta Endocrinol (Kbh) 70:487–509, 1972

    Google Scholar 

  26. Widdonson GM, Penton JR: Determination of serum and plasma glucose on “autoanalyzer II” by use of hexokinase reaction. Clin Chem 18:299–300, 1972

    Google Scholar 

  27. Malagelada J-R, Longstreth GF, Summerskill WHJ, Go VLW: Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70:203–210, 1976

    Google Scholar 

  28. Debas HT: Peripheral regulation of gastric secretion.In Physiology of the Gastrointestinal Tract, 2nd ed. LR Johnson (ed). New York, Raven Press, 1987, pp 931–945

    Google Scholar 

  29. Solomon TE: Control of exocrine pancreatic secretion.In Physiology of the Gastrointestinal Tract, 2nd ed. LR Johnson (ed). New York, Raven Press, 1987, pp 1173–1208

    Google Scholar 

  30. Kosaka T, Lim RKS: Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 27:890–891, 1980

    Google Scholar 

  31. Harper AA, Hood AJC, Mushens J, Smy JR: Pancreotone, an, inhibitor of pancreatic secretion in extracts of ileal and colonic mucosa. J Physiol (London) 292:455–467, 1979

    Google Scholar 

  32. Olsen PS, Pedersen JH, Kirkegaard P, Been H, Stadil F: Neurotensin induced inhibition of acid secretion in duodenal ulcer patients before and after vagotomy. Gut 25:481–484, 1984

    Google Scholar 

  33. Mogard MH, Maxwell VE, Sytnik B, Walsh JH: Regulation of gastric acid secretion by neurotensin in man: Evidence against a hormonal role. J Clin Invest 80:1064–1067, 1987

    Google Scholar 

  34. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR: Effect of peptide YY on gastric, pancreatic and biliary functions in humans. Gastroenterology 89:494–499, 1985

    Google Scholar 

  35. Luis F, Gomez G, Fujinura M, Greeley GH Jr, Thompson JC: Peptide YY inhibits nutrient, hormonal and vagally stimulated pancreatic exocrine secretion. Pancreas 2:454–462, 1987

    Google Scholar 

  36. Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz T, Sundler F: Coexistence of PYY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 8:261–266, 1984

    Google Scholar 

  37. Kirkegaard P, Loud FB, Moody AJ, Holst JJ, Christiansen J: Gut GLI inhibits gastric acid secretion in the rat. Nature 297:156–157, 1982

    Google Scholar 

  38. Miholic J, Ørskov C, Holst JJ, Kotserke J, Meyer HJ: Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36:1361–1370, 1991

    Google Scholar 

  39. Holst JJ, Rasmussen TN, Harling H, Schmidt P: Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. Pancreas (in press)

  40. Ørskov C: Glucagon-like peptide-1. Diabetologia 35:701–711, 1992

    Google Scholar 

  41. Gutniak M, Ørskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-like peptide-1 (7–36)amide in normal subjects and patients with diabetes, mellitus. N Engl J Med 326:1316–1322, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by the Danish Hospital Foundation for Medical Research, Region of Copenhagen, The Faroe Islands and Greenland; the Danish Medical Research Council, and the Novo Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wettergren, A., Schjoldager, B., Mortensen, P.E. et al. Truncated GLP-1 (proglucagon 78–107-amide) inhibits gastric and pancreatic functions in man. Digest Dis Sci 38, 665–673 (1993). https://doi.org/10.1007/BF01316798

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01316798

Key Words

Navigation